Stone M
Cardiff Royal Infirmary.
Br J Hosp Med. 1993;49(4):275-7.
Didronel PMO is a new treatment, comprising cyclical disodium etidronate and calcium carbonate, for women with postmenopausal osteoporosis who already have one or more vertebral fractures. Vertebral fracture rates can be reduced by 50% after treatment for 2 years.
Didronel PMO是一种新的治疗方法,由周期性使用的依替膦酸二钠和碳酸钙组成,用于已经发生一处或多处椎体骨折的绝经后骨质疏松症女性。治疗2年后,椎体骨折率可降低50%。